Atripla
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Several studies have reported an increased incidence of auditory dysfunction among HIV/AIDS patients. We used auditory HEI-OC1…
IntroductionIn August 2012, the US Food and Drug Administration (FDA) approved a new single tablet once-a-day therapy for…
The British HIV Association (BHIVA) 2012 guidelines for the treatment of HIV recommend patients start combination antiretroviral…
Atripla is a fixed‐dose drug combining FTC/TDF/EFV into a single pill and may increase adherence. To our knowledge, there is…
A new HIV regimen that combines four medications into one pill, known as Quad, has been shown to be safe and effective, and may…
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Gilead Sciences has reported phase II clinical trial results on their investigational fixed-dose single-tablet ‘‘Quad’’ regimen…
Correspondence: Johannes Bogner Medizinische Poliklinik der LMU München, Department of infectious diseases Pettenkoferstrasse 8a…
In developed countries, drug therapy has turned HIV infection into a chronic disease. More is known about viral replication and…
With the increasing of patients infected by HIV, the study of anti-viral drugs has become one of the most important projects.This…